Abstract
Malignant pulmonary lymphomas are a heterogeneous group of malignancies characterized by the clonal proliferation of lymphocytes within the lung. They are classified as primary, arising in the lung without extrathoracic involvement (mostly mucosa-associated lymphoid tissue lymphoma), or secondary, resulting from the spread of systemic lymphoma, often diffuse large B-cell or Hodgkin lymphoma. Imaging findings correlate with histopathologic features, showing single or multiple nodules/masses, lobar or segmental consolidations, reticular patterns, or disseminated small nodules. Although a definitive diagnosis relies on histopathological and immunophenotypic analysis, imaging plays a crucial role in early suspicion, lesion localization, disease staging, and monitoring treatment response or recurrence.
| Original language | English |
|---|---|
| Pages (from-to) | 301-316 |
| Number of pages | 16 |
| Journal | Seminars in Ultrasound, CT and MRI |
| Volume | 46 |
| Issue number | 4 |
| DOIs | |
| State | Published - Sep 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Imaging of Pulmonary Malignant Lymphoproliferative Disorders'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver